Charles Bernick

ORCID: 0000-0003-4040-3587
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Traumatic Brain Injury Research
  • Dementia and Cognitive Impairment Research
  • Alzheimer's disease research and treatments
  • Functional Brain Connectivity Studies
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Advanced Neuroimaging Techniques and Applications
  • Advanced MRI Techniques and Applications
  • Neurological Disease Mechanisms and Treatments
  • Psychosomatic Disorders and Their Treatments
  • Bioinformatics and Genomic Networks
  • Cardiac Arrest and Resuscitation
  • Cerebrovascular and Carotid Artery Diseases
  • Genetic Associations and Epidemiology
  • Cerebrospinal fluid and hydrocephalus
  • Cardiovascular Effects of Exercise
  • Health, Environment, Cognitive Aging
  • Statistical Methods in Clinical Trials
  • Brain Tumor Detection and Classification
  • Occupational Health and Performance
  • Acute Ischemic Stroke Management
  • Suicide and Self-Harm Studies
  • Machine Learning in Healthcare
  • Neurological Disorders and Treatments
  • Machine Learning in Bioinformatics
  • Neuroinflammation and Neurodegeneration Mechanisms

Cleveland Clinic
2016-2025

Lou Ruvo Brain Institute
2016-2025

University of Washington
2004-2025

Mayo Clinic in Arizona
2021-2025

University of Pennsylvania
2004-2024

Johns Hopkins Medicine
2024

Johns Hopkins University
2001-2024

University of Florida
2024

University of Connecticut
2024

Boston University
2021-2024

<i>Background:</i> Silent infarcts are commonly discovered on cranial MRI in the elderly. <i>Objective:</i> To examine association between risk of stroke and presence silent infarcts, alone combination with other factors. <i>Methods:</i> Participants (3,324) Cardiovascular Health Study (CHS) without a history underwent scans 1992 1994. were defined as focal lesions greater than 3 mm that hyperintense T2 images and, if subcortical, hypointense T1 images. Incident strokes identified classified...

10.1212/wnl.57.7.1222 article EN Neurology 2001-10-09

Background and Purpose— We have previously reported that several “silent” infarcts found on magnetic resonance imaging (MRI) were a risk factor for stroke. Several recent reports shown high white matter grade (WMG) increasing WMG over time factors tested the hypothesis ≥2 was predictor of stroke, independent other factors. Methods— examined extent hyperintensity cranial MRI 3293 participants from Cardiovascular Health Study (CHS). The degree graded least severe (grade=0) to most (grade=9)....

10.1161/01.str.0000132193.35955.69 article EN Stroke 2004-06-08

Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) reduce cardiovascular risk through mechanisms that might affect the development of dementia.To evaluate whether statin use is associated with a lower dementia compared never lipid-lowering agents (LLAs).Cohort study community-dwelling adults 65 years and older. The analysis included 2798 participants free at baseline.Using Cox proportional hazards regression analysis, we estimated incident all-cause type-specific...

10.1001/archneur.62.7.1047 article EN Archives of Neurology 2005-07-01

Few population-based studies have examined in detail issues of stroke-related deaths elderly people.Participants the Cardiovascular Health Study (CHS) are 65 years age or older, had extensive baseline evaluations, and been followed-up for fatal nonfatal cardiovascular cerebrovascular disease outcomes. Investigators adjudicated these outcomes classified strokes by types subtypes.Over 7 years, 1,310 (22.2%) 5,888 participants died, 455 (7.7%) experienced incident stroke. For 5,888, stroke...

10.1212/wnl.56.3.368 article EN Neurology 2001-02-13
David A. Wolk Bradford C. Dickerson Michael D. Weiner Marilyn Aiello Paul Aisen and 95 more Marilyn Albert Gene E. Alexander Heather S. Anderson Karen Anderson Liana Apostolova S. R. Arnold Wes Ashford Michele Assaly Sanjay Asthana Dan Bandy Robert Bartha Vernice Bates Laurel Beckett Karen L. Bell Amanda L. Benincasa Howard Bergman Charles Bernick Matt A. Bernstein Sandra E. Black Karen Blank Michael Borrie Connie Brand James Brewer Alice D. Brown Jeffrey M. Burns Nigel J. Cairns Curtis Caldwell Horacio Capote Cynthia M. Carlsson Owen Carmichael Janet S. Cellar Dzintra Celmins Kewei Chen Howard Chertkow Munir Chowdhury David A. Clark Donald J. Connor Stephen Correia Karen Crawford Anders M. Dale Mony J. de Leon Susan M De Santi Charles DeCarli Leyla deToledo‐Morrell Michael D. Devous Ramon Diaz‐Arrastia Sara Dolen Michael Donohue Rachelle S. Doody P. Murali Doraiswamy Ranjan Duara Jessica Englert Martin Farlow Howard Feldman Joel P. Felmlee Adam Fleisher E. Fletcher Tatiana Foroud Norm Foster Nick C. Fox R.T. Frank Anthony Gamst Curtis A. Given Neill R. Graff‐Radford Robert C. Green Randall Griffith Hillel Grossman Ann Marie Hake Peter Hardy Danielle Harvey Judith L. Heidebrink Barry Hendin Scott Herring Lawrence S. Honig Chris Hosein Ging‐Yuek Robin Hsiung Leon Hudson M. Saleem Ismail Clifford R. Jack Sandra A. Jacobson William J. Jagust Annapurni Jayam‐Trouth Kris Johnson Heather Johnson Nancy Johnson Kathleen Johnson Keith A. Johnson Sterling C. Johnson Zaven Kachaturian Jason Karlawish Maria Kataki Jeffrey Kaye Andrew Kertesz Ronald Killiany Smita Kittur

The ε4 allele of the apolipoprotein E (APOE) gene is major genetic risk factor for Alzheimer’s disease (AD), but limited work has suggested that APOE genotype may modulate phenotype. Carriers have been reported to greater medial temporal lobe (MTL) pathology and poorer memory than noncarriers. Less attention focused on whether there are domains cognition neuroanatomical regions more affected in Further, a potential confound prior vivo studies possibility different rates clinical misdiagnosis...

10.1073/pnas.1001412107 article EN Proceedings of the National Academy of Sciences 2010-05-17

Abstract Introduction This clinical trial evaluates the efficacy and safety of a 6‐week course daily neuroAD™ therapy. Methods 131 subjects between 60 90 years old, unmedicated for Alzheimer's disease (AD), or on stable doses an acetylcholinesterase inhibitor and/or memantine, with Mini–Mental State Examination scores 18 26, dementia rating scale 1 2, enrolled prospective, randomized, double‐blind, sham‐controlled, multicenter trial. Structural brain MRIs were obtained transcranial magnetic...

10.1016/j.jalz.2019.08.197 article EN Alzheimer s & Dementia 2019-12-24

<h3>Objective:</h3> We tested biweekly infusions of IV immunoglobulin (IVIg) as a possible treatment for mild to moderate Alzheimer disease (AD) dementia. <h3>Methods:</h3> In phase 3, double-blind, placebo-controlled trial, we randomly assigned 390 participants with AD receive placebo (low-dose albumin) or IVIg (Gammagard Liquid; Baxalta, Bannockburn, IL) administered at doses 0.2 0.4 g/kg every 2 weeks 18 months. The primary cognitive outcome was change from baseline months on the 11-item...

10.1212/wnl.0000000000003904 article EN Neurology 2017-04-06

Cumulative head trauma may alter brain structure and function. We explored the relationship between exposure variables, cognition MRI structural measures in a cohort of professional combatants.224 fighters (131 mixed martial arts 93 boxers) participating Professional Fighters Brain Health Study, longitudinal study licensed combatants, were recruited, as 22 controls. Each participant underwent computerised cognitive testing volumetric MRI. Fighting history including years fighting fights per...

10.1136/bjsports-2014-093877 article EN cc-by-nc British Journal of Sports Medicine 2015-01-29

<b>Objective: </b> To examine the association of statin drug use on cognitive and MRI change in older adults. <b>Methods: Participants Cardiovascular Health Study, a longitudinal study people age 65 or older, were classified into three groups determined by whether they taking drugs continuous basis, intermittently, not at all. The untreated group was further divided categories based National Cholesterol Education Program recommendations for lipid-lowering treatment. with prevalent incident...

10.1212/01.wnl.0000182897.18229.ec article EN Neurology 2005-11-08

Cerebral microvascular disease may be a risk factor for the development of dementia in elderly persons. We describe association retinal signs with cognitive function and among older individuals.In population-based Cardiovascular Health Study, 2211 persons aged 69 to 97 years at recruitment had photography. Photographs were evaluated retinopathy (eg, microaneurysms, hemorrhages), focal arteriolar narrowing, arteriovenous nicking, venular caliber. Cognitive status was determined from...

10.1161/strokeaha.107.483586 article EN Stroke 2007-05-25

Traumatic brain injury is common in fighting athletes such as boxers, given the frequency of blows to head. Because DTI sensitive microstructural changes white matter, this technique often used investigate matter integrity patients with traumatic injury. We hypothesized that previous fight exposure would predict abnormalities after controlling for individual variation.A total 74 boxers and 81 mixed martial arts fighters were included analysis scanned by use DTI. Individual information data...

10.3174/ajnr.a3676 article EN cc-by American Journal of Neuroradiology 2013-08-08

Repetitive head trauma is a risk factor for Alzheimer's disease and the primary cause of chronic traumatic encephalopathy. However, little known about natural history of, factors for, encephalopathy or means early detection intervention. The Professional Fighters Brain Health Study longitudinal study active professional fighters (boxers mixed martial artists), retired fighters, controls matched age level education. main objective to determine relationships between measures exposure other...

10.1093/aje/kws456 article EN American Journal of Epidemiology 2013-06-04

Factors that affect the rate of progression Alzheimer disease (AD) need to be considered in clinical trial designs potential disease-modifying therapies.To determine influence age on AD course a setting.Pooled cohort study from 3 trials 18-month duration conducted by Disease Cooperative Study group.Alzheimer research centers across United States.Four hundred seventy-one subjects with mild moderate assigned placebo arm trials.The relationships between baseline and change Assessment...

10.1001/archneurol.2011.3758 article EN Archives of Neurology 2012-03-20

Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease that has been neuropathologically diagnosed in brain donors exposed to repetitive head impacts, including boxers and American football, soccer, ice hockey, rugby players. CTE cannot yet be during life. In December 2015, the National Institute of Neurological Disorders Stroke awarded seven-year grant (U01NS093334) fund "Diagnostics, Imaging, Genetics Network for Objective Study Evaluation Traumatic Encephalopathy (DIAGNOSE...

10.1186/s13195-021-00872-x article EN cc-by Alzheimer s Research & Therapy 2021-08-12
Michael L. Alosco William Barr Sarah J. Banks Jennifer V. Wethe Justin B. Miller and 95 more Surya Pulukuri Julia Culhane Yorghos Tripodis Charles H. Adler Laura J. Balcer Charles Bernick Megan Mariani Robert C. Cantu David W. Dodick Michael D. McClean Rhoda Au Jesse Mez Robert Turner Joseph Palmisano Brett Martin Kaitlin Hartlage Jeffrey L. Cummings Eric M. Reiman Martha E. Shenton Robert A. Stern Yi Su Kewei Chen Hillary Protas Connie Boker Lindsay A. Farrer Robert Helm Douglas I. Katz Neil W. Kowall Gustavo Mercier James Otis Jason Weller Irene Simkin Alondra Andino Shannon E. Conneely Courtney Diamond Tessa Fagle Olivia Haller Tennyson Hunt Nicole Gullotti Brian Mayville Kathleen McLaughlin Mary Nanna Taylor Platt Fiona Rice Madison Sestak Douglas S. Annis Christine E. Chaisson Diane Dixon Carolyn Finney Kerrin Gallagher Jun Lü EO Ojo Brittany Pine Janani Ramachandran Sylvain Bouix Jennifer Fitzsimmons Alexander P. Lin Inga K. Koerte Ofer Pasternak Hector Arciniega Tashrif Billah Elena M. Bonke Katherine M. Breedlove Eduardo Coello Michael J. Coleman Leonhard Jung Huijun Liao Maria Loy Elizabeth Rizzoni Vivian Schultz Annelise Silva Brynn Vessey Tim L. T. Wiegand Aaron Ritter Marwan N. Sabbagh Raelynn de la Cruz Jan Durant Morgan Golceker Nicolette Harmon Kaeson Kaylegian Rachelle Long Christin Nance Priscilla Sandoval Kenneth Marek Andrew Serrano Yonas E. Geda Bryce W. Falk Amy Duffy Marci Howard Michelle Montague Thomas Osgood Debra Babcock Patrick S.F. Bellgowan Judith D. Goldberg Thomas Wısnıewskı

Abstract Background Patterns of cognitive impairment in former American football players are uncertain because objective neuropsychological data lacking. This study characterized the test performance college and professional players. Methods One hundred seventy male ( n =111 professional, =59 college; 45–74 years) completed a battery. Raw scores were converted to T -scores using age, sex, education-adjusted normative data. A -score ≤ 35 defined impairment. domain was impaired if 2+ fell...

10.1186/s13195-022-01147-9 article EN cc-by Alzheimer s Research & Therapy 2023-01-03

The aim of this study is to evaluate longitudinal change in plasma neurofilament light (NF-L) and tau levels relationship clinical radiological measures professional fighters. Participants (active retired fighters control group) underwent annual blood sampling, 3-Tesla magnetic resonance imaging (MRI) brain imaging, computerized cognitive testing, assessment exposure traumatic injury. Plasma NF-L concentrations were measured using Simoa assays. Multiple linear regression models used compare...

10.1089/neu.2017.5553 article EN Journal of Neurotrauma 2018-04-03
Coming Soon ...